ATE477255T1 - Imidazobenzdiazepinderivate - Google Patents

Imidazobenzdiazepinderivate

Info

Publication number
ATE477255T1
ATE477255T1 AT06806921T AT06806921T ATE477255T1 AT E477255 T1 ATE477255 T1 AT E477255T1 AT 06806921 T AT06806921 T AT 06806921T AT 06806921 T AT06806921 T AT 06806921T AT E477255 T1 ATE477255 T1 AT E477255T1
Authority
AT
Austria
Prior art keywords
derivatives
imidazobenzdiazepine
cognitive
triazolo
gaba
Prior art date
Application number
AT06806921T
Other languages
English (en)
Inventor
Bernd Buettelmann
Henner Knust
Andrew William Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE477255T1 publication Critical patent/ATE477255T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Lubricants (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT06806921T 2005-10-11 2006-10-02 Imidazobenzdiazepinderivate ATE477255T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05109446 2005-10-11
PCT/EP2006/066960 WO2007042421A1 (en) 2005-10-11 2006-10-02 Imidazo benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
ATE477255T1 true ATE477255T1 (de) 2010-08-15

Family

ID=37638034

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06806921T ATE477255T1 (de) 2005-10-11 2006-10-02 Imidazobenzdiazepinderivate

Country Status (13)

Country Link
US (1) US7507729B2 (de)
EP (1) EP1937688B1 (de)
JP (1) JP4885967B2 (de)
KR (1) KR101009860B1 (de)
CN (1) CN101287738B (de)
AT (1) ATE477255T1 (de)
AU (1) AU2006301377B2 (de)
BR (1) BRPI0617204A2 (de)
CA (1) CA2625611A1 (de)
DE (1) DE602006016147D1 (de)
ES (1) ES2348356T3 (de)
IL (1) IL190398A0 (de)
WO (1) WO2007042421A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2913886B1 (fr) 2007-03-22 2012-03-02 Guerbet Sa Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer
CN102753545A (zh) * 2009-12-15 2012-10-24 盐野义制药株式会社 具有血管内皮脂酶抑制活性的噁二唑衍生物
EP2457569A1 (de) 2010-11-05 2012-05-30 F. Hoffmann-La Roche AG Verwendung aktiver pharmazeutischer Verbindungen zur Behandlung von Erkrankungen des zentralen Nervensystems
SG189248A1 (en) * 2010-11-05 2013-06-28 Hoffmann La Roche Use of active pharmaceutical compounds for the treatment of central nervous system conditions
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
EP3083569B1 (de) 2013-12-20 2022-01-26 Agenebio, Inc. Benzodiazepinderivate, zusammensetzungen und verfahren zur behandlung von kognitiven störungen
CA2990004C (en) 2015-06-19 2024-04-23 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
EA202190076A1 (ru) 2018-06-19 2021-09-22 Эйджинбайо, Инк. Производные бензодиазепина, композиции и способы лечения когнитивных нарушений
CN113480447A (zh) * 2021-07-14 2021-10-08 东莞理工学院 一种合成乳酰肼的方法
CN116102557B (zh) * 2021-11-09 2024-04-26 四川大学华西医院 苯二氮卓类化合物及其制备方法和在医药上的用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146721A (en) 1969-09-12 1979-03-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyrazol-4-acetic acid compounds
DE2940189A1 (de) 1979-10-04 1981-04-16 Basf Ag, 6700 Ludwigshafen Isoxazolylcarbonsaeureanilide, verfahren zu ihrer herstellung und ihre verwendung als fungizide
AU7474881A (en) 1980-08-27 1982-03-04 Glaxo Group Limited 1,2,4-triazole derivatives
AU582214B2 (en) 1985-02-11 1989-03-16 Upjohn Company, The Anthelmintic pyridinyl acylhydrazones, method of use and compositions
US5098920A (en) 1990-05-04 1992-03-24 G. D. Searle & Co. 1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders
TW201311B (de) * 1991-06-17 1993-03-01 Hoffmann La Roche
JPH06242977A (ja) * 1993-02-16 1994-09-02 Mitsubishi Electric Corp 1チップマイクロプロセッサ
US5635103A (en) 1995-01-20 1997-06-03 The Procter & Gamble Company Bleaching compositions and additives comprising bleach activators having alpha-modified lactam leaving-groups
US5656629A (en) 1995-03-10 1997-08-12 Sanofi Winthrop, Inc. 6-substituted pyrazolo (3,4-d)pyrimidin-4-ones and compositions and methods of use thereof
DE19602505A1 (de) 1996-01-25 1997-07-31 Merck Patent Gmbh 1-(Pyrazol-4-Indol-3-yl)-Piperidine
EP1085371B1 (de) 1999-09-15 2003-08-06 Agfa-Gevaert Einen neuen Hydrazidtyp enthaltendes photographisches Material
TWI239333B (en) * 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
GB2380190A (en) 2001-08-28 2003-04-02 Bayer Ag Antiinflammatory heterocyclic sulphones
CA2581918A1 (en) * 2004-10-12 2006-04-20 Henner Knust Imidazo(1,5-a)triazolo(1,5-d) benzodiazepine deratives for the treatment of cognitive disorders
EP1805184B1 (de) * 2004-10-20 2013-01-09 F. Hoffmann-La Roche AG Imidazobenzodiazepin-derivate
MX2007004640A (es) * 2004-10-20 2007-06-08 Hoffmann La Roche Derivados de benzodiazepina sustituidos con halogeno.

Also Published As

Publication number Publication date
AU2006301377B2 (en) 2012-03-08
AU2006301377A1 (en) 2007-04-19
CA2625611A1 (en) 2007-04-19
US20070082890A1 (en) 2007-04-12
JP4885967B2 (ja) 2012-02-29
ES2348356T3 (es) 2010-12-03
DE602006016147D1 (en) 2010-09-23
IL190398A0 (en) 2008-11-03
KR101009860B1 (ko) 2011-01-19
EP1937688B1 (de) 2010-08-11
CN101287738A (zh) 2008-10-15
US7507729B2 (en) 2009-03-24
EP1937688A1 (de) 2008-07-02
CN101287738B (zh) 2011-08-10
BRPI0617204A2 (pt) 2011-07-19
JP2009511534A (ja) 2009-03-19
KR20080063496A (ko) 2008-07-04
WO2007042421A1 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
ATE477255T1 (de) Imidazobenzdiazepinderivate
TW200630372A (en) Imidazo-benzodiazepine derivatives
DK1869049T3 (da) Imidazopyridazinforbindelser
IL189762A0 (en) Isoxazolo derivatives as gaba a alpha5 inverse agonists
IL194947A0 (en) Aryl-4-ethynyl-isoxazole derivatives
TW200745121A (en) Chemical compound
BRPI0618383A2 (pt) derivados de 3-aril-isoxazol-4-carbonil-benzofurano
MX2007004640A (es) Derivados de benzodiazepina sustituidos con halogeno.
DE60326060D1 (de) Nichtvernetzende pyrroloä2,1-cüä1,4übenzodiazepine als potentielle antitumor-agentien und ihre herstellung
TW200621716A (en) Novel compounds
TW200631953A (en) Tetracyclic imidazo-benzodiazepines
TW200611701A (en) Novel compounds
MA29623B1 (fr) Derives de pyrazolo [3, 4-d] azepine comme antagonistes d'histamine h3
WO2005103052A8 (en) Pyrazolo [1,5-a] pyrimidin-7-one compounds and uses thereof
GB2446080A (en) A novel Pyrrolo [2,1-C][1,4] benzodiazepine hybrid and a process for the preparation thereof
DE60312328D1 (de) Substituierte hexahydropyrrolo(1,2-a)pyrazine, octahydropyrido(1,2-a)pyrazine und decahydropyrazino(1,2-a)azepine
BRPI0606730A2 (pt) derivados de fenil metanona 2,5-di-substituìdos como inibidores do transportador de glicina 1 (glyt-1) para o tratamento de distúbios neurológicos e neuropsiquiátricos
MXPA06000774A (es) E3-nitro-pirazolo[1,5-a]pirimidinas 7-sustituidas y composiciones y metodos relacionados.
TH79587B (th) อนุพันธ์ของอิมิดาโซ-เบนโซไดอะซีพีน
TH79587A (th) อนุพันธ์ของอิมิดาโซ-เบนโซไดอะซีพีน
TH82743A (th) อนุพันธ์เบนโซไดอะซีพีนซึ่งถูกแทนที่ด้วยฮาโลเจน

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1937688

Country of ref document: EP